There are millions of people worldwide are suspected to have OSA, of which a majority remain undiagnosed. Lack of awareness among patients and physicians is one of the primary reasons for low penetration of sleep apnea diagnosis as well as therapy. However, since the turn of the millennium, awareness has increased rapidly due to co-morbidities such as diabetes, congestive heart failure and hypertension, associated with OSA.

These and other market data and trends are presented in "Sleep Apnea Diagnostic and Therapeutic Devices: Worldwide Market Challenges & Opportunities" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Read via prnewswire.com